Why AbbVie Stock Is Jumping Today
Shares of (NYSE: ABBV) were jumping 4.2% higher as of 11:37 a.m. ET on Thursday. The nice gain came after the big drugmaker revealed that it had settled litigation with all companies that have filed abbreviated new drug applications (ANDAs) with the U.S. Food and Drug Administration (FDA) to make generic versions of AbbVie's autoimmune disease drug Rinvoq.
AbbVie currently awaits pediatric exclusivity for Rinvoq. If this is granted, the company doesn't expect generic competition for the drug before April 2037 in the U.S.
Image source: Getty Images.
Source Fool.com
AbbVie Inc. Stock
€196.80
1.340%
With 42 Buy predictions and not a single Sell prediction AbbVie Inc. is an absolute favorite of our community.
With a target price of 205 € there is a slightly positive potential of 4.17% for AbbVie Inc. compared to the current price of 196.8 €.
